September 30, 2021
【Original Research Article】An article has been published in “Nutrients”.
An article by Dr. Zen Tanaka (President , Tanaka Clinic, Jinzenkai Medical Corporation ), President of our study group, was published in “Nutrients”. Optimizing nutrients, digestive capacity, and immunity is important to reduce the risk of cancer. The first and most important step in this process is to optimize gut bacteria. In the paper, the […]
September 21, 2021
Thank you for holding the 5th Annual Scientific Meeting
The 5th Annual Scientific Meeting” was held on September 19, 2011. This year’s event was again held on a reduced scale to prevent the spread of the new coronavirus, but with the support and cooperation of many people, we were able to hold the event both onsite and online. Medical professionals, general business people, research […]
September 06, 2021
“NanoGAS” was registered as a trademark.
We are pleased to announce that “NanoGAS” (read: nano-gas), for which Symbiosis, Inc. filed an application with the Japan Patent Office, was registered as a trademark on August 19, 2021. Synbiosis’ proprietary Ultra Fine Bubble (UFB) water containing invisible microscopic bubbles is called “NanoGAS®” and this technology is also used in the bacterial solution for […]
August 25, 2021
5th Annual Conference, abstract presentation!
The abstracts for the 5th Annual Meeting, to be held on September 19 (Sun.) from 11:00 a.m., have been decided. Dr. Zen Tanaka ( President, Tanaka Clinic, Jinzenkai Medical Corporation) will open the session with “Future Clinical Research in the Intestinal Flora Transplantation Clinical Study Group – Cancer and Renal Diseases”. FROM THE VIEWPOINT OF […]
August 13, 2021
August Special Study Session by Regular Members was held
The August special study session was held on Friday, August 6 by regular member doctors. THIS TIME, WE INVITED DR. TAIICHI KATAYAMA OF THE UNITED GRADUATE SCHOOL OF CHILD DEVELOPMENT, OSAKA UNIVERSITY, WHO WAS INVITED TO DELIVER THE KEYNOTE LECTURE AT THE 5TH ANNUAL CONFERENCE SCHEDULED FOR SEPTEMBER 19, TO LUKE’S ASHIYA CLINIC IN HYOGO […]
July 26, 2021
A debriefing session for the relocation of the Kobe Laboratory and Plant of Symbiosis, Inc. was held.
We are pleased to announce that Symbiosis Inc. has moved to the Innovation Lab “Hidec” on Port Island in Kobe Medical Industry City. On July 24 (Sat.), we held a debriefing for the relocation, which was attended by doctors from affiliated medical institutions as well as many of the people who have been taking care […]
April 12, 2021
The NanoGAS™ series has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine.
Synbiosis’ proprietary NanoGAS™ series, which supports our group’s transplantation bacteriological solutions, has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine. The transplanted bacteria solution used in our research group is Ultra Fine Bubble (NanoGAS™) water, which contains invisible microscopic bubbles.By utilizing the properties of Ultra Fine Bubble, we […]
December 08, 2020
The 4th Annual Conference [Report]
The 4th Annual Meeting, held on Monday, September 21, 2020 (national holiday), was held onsite and online with a reduced size venue from the perspective of preventing and spreading novel coronavirus infection.Although the conference was held in cooperation with infection prevention efforts, it was a very meaningful day attended by medical professionals, general business people, […]
November 09, 2020
Efforts of our study group’s stool bank Japanbiome on new coronaviruses
The Intestinal Flora Transplant Clinical Research Foundation and Japanbiome (Intestinal Flora Transplant Donor Bank) are working to ensure that patients who wish to receive an intestinal flora transplant can do so with peace of mind.The number of patients who wish to undergo intestinal flora transplantation has been increasing as academic reports recognizing the usefulness of […]
October 16, 2020
Adverse Event Report has been updated.
The intestinal flora transplantation performed by our study group takes the form of clinical application by clinicians nationwide and is formally self-funded. HOWEVER, BECAUSE THE NEW TREATMENT METHOD OF INTESTINAL FLORA TRANSPLANTATION IS ATTRACTING A GREAT DEAL OF ATTENTION AROUND THE WORLD, AND IN THE UNITED STATES, IT HAS BEEN ESTABLISHED AS A TREATMENT METHOD […]
